Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -133,746 | -109,954 | -120,324 | -97,183 | -72,900 |
| Depreciation Amortization | 2,830 | 3,254 | 2,683 | 1,202 | 471 |
| Accounts receivable | -388 | 649 | -591 | 931 | -1,019 |
| Accounts payable and accrued liabilities | 274 | 1,780 | -1,515 | 3,251 | -1,436 |
| Other Working Capital | 65,932 | 26,888 | 70,660 | 17,898 | 63,179 |
| Other Operating Activity | 24,429 | 31,676 | 39,670 | 23,655 | 6,262 |
| Operating Cash Flow | $-40,669 | $-45,707 | $-9,417 | $-50,246 | $-5,443 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,317 | -48,370 | -181,766 | N/A | N/A |
| PPE Investments | -6,065 | -4,717 | -2,044 | -3,473 | -1,431 |
| Investing Cash Flow | $12,252 | $-53,087 | $-183,810 | $-3,473 | $-1,431 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,500 |
| Debt Repayment | N/A | -857 | -764 | -560 | N/A |
| Common Stock Issued | 131,824 | 87,797 | 155,898 | 97,721 | 6 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1,746 |
| Other Financing Activity | 0 | 0 | -600 | 0 | 139,631 |
| Financing Cash Flow | $131,824 | $86,940 | $154,534 | $97,161 | $139,391 |
| Beginning Cash Position | 136,395 | 148,249 | 186,942 | 143,500 | 10,983 |
| End Cash Position | 239,802 | 136,395 | 148,249 | 186,942 | 143,500 |
| Net Cash Flow | $103,407 | $-11,854 | $-38,693 | $43,442 | $132,517 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,669 | -45,707 | -9,417 | -50,246 | -5,443 |
| Capital Expenditure | -6,167 | -4,754 | -2,059 | -3,493 | -1,431 |
| Free Cash Flow | -46,836 | -50,461 | -11,476 | -53,739 | -6,874 |